160 related articles for article (PubMed ID: 38160960)
1. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines.
Hromić-Jahjefendić A; Lundstrom K; Adilović M; Aljabali AAA; Tambuwala MM; Serrano-Aroca Á; Uversky VN
Autoimmun Rev; 2024 Mar; 23(3):103508. PubMed ID: 38160960
[TBL] [Abstract][Full Text] [Related]
2. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
Mohkhedkar M; Venigalla SSK; Janakiraman V
Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity.
Jaycox JR; Lucas C; Yildirim I; Dai Y; Wang EY; Monteiro V; Lord S; Carlin J; Kita M; Buckner JH; Ma S; Campbell M; Ko A; Omer S; Lucas CL; Speake C; Iwasaki A; Ring AM
Nat Commun; 2023 Mar; 14(1):1299. PubMed ID: 36894554
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R
Front Immunol; 2021; 12():686462. PubMed ID: 34276672
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
6. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
Vojdani A; Vojdani E; Kharrazian D
Front Immunol; 2020; 11():617089. PubMed ID: 33584709
[TBL] [Abstract][Full Text] [Related]
7. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
[TBL] [Abstract][Full Text] [Related]
8. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.
Karami Fath M; Jahangiri A; Ganji M; Sefid F; Payandeh Z; Hashemi ZS; Pourzardosht N; Hessami A; Mard-Soltani M; Zakeri A; Rahbar MR; Khalili S
Front Immunol; 2021; 12():705772. PubMed ID: 34447375
[TBL] [Abstract][Full Text] [Related]
10. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
Ghielmetti M; Schaufelberger HD; Mieli-Vergani G; Cerny A; Dayer E; Vergani D; Terziroli Beretta-Piccoli B
J Autoimmun; 2021 Sep; 123():102706. PubMed ID: 34293683
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and autoimmune diseases.
Liu Y; Sawalha AH; Lu Q
Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
[TBL] [Abstract][Full Text] [Related]
12. Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion.
Simon D; Tascilar K; Schmidt K; Manger B; Weckwerth L; Sokolova M; Bucci L; Fagni F; Manger K; Schuch F; Ronneberger M; Hueber A; Steffen U; Mielenz D; Herrmann M; Harrer T; Kleyer A; Krönke G; Schett G
Arthritis Rheumatol; 2022 Jan; 74(1):33-37. PubMed ID: 34196506
[TBL] [Abstract][Full Text] [Related]
13. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
Vahabi M; Ghazanfari T; Sepehrnia S
Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
[TBL] [Abstract][Full Text] [Related]
14. Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.
Connolly CM; Teles M; Frey S; Boyarsky BJ; Alejo JL; Werbel WA; Albayda J; Christopher-Stine L; Garonzik-Wang J; Segev DL; Paik JJ
Ann Rheum Dis; 2022 Feb; 81(2):291-293. PubMed ID: 34493492
[No Abstract] [Full Text] [Related]
15. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune complications of COVID-19.
Yazdanpanah N; Rezaei N
J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
[TBL] [Abstract][Full Text] [Related]
17. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
Elife; 2021 Oct; 10():. PubMed ID: 34636722
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis.
Velikova T; Georgiev T
Rheumatol Int; 2021 Mar; 41(3):509-518. PubMed ID: 33515320
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature.
Ruggeri RM; Giovanellla L; Campennì A
J Endocrinol Invest; 2022 Dec; 45(12):2283-2289. PubMed ID: 35829989
[TBL] [Abstract][Full Text] [Related]
20. Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease.
Malipiero G; Moratto A; Infantino M; D'Agaro P; Piscianz E; Manfredi M; Grossi V; Benvenuti E; Bulgaresi M; Benucci M; Villalta D
Immunol Res; 2021 Dec; 69(6):576-583. PubMed ID: 34417958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
